Sunitinib Malate Capsule
Product Images NDC 63304-092

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 63304-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sunitinib-25mg-label (Spl Sunitinib 25mg Label)

FDA Label Image

Spl-sunitinib-50mg-label (Spl Sunitinib 50mg Label)

FDA Label Image

Spl-sunitinib-capsules-label1 (Spl Sunitinib Capsules Label1)

FDA Label Image

Spl-sunitinib-capsules-label3 (Spl Sunitinib Capsules Label3)

FDA Label Image

Spl-sunitinib-figure1 (Spl Sunitinib Figure1)

This text presents data on the time of tumor progression in two groups of patients, one treated with a certain therapy ("Suaitiaib") and another group receiving a placebo. The number of patients in each group is mentioned (207 and 105, respectively). The median time of tumor progression for the "Suaitiaib" group was 27.3 weeks, while for the placebo group it was 6.4 weeks. A hazard ratio value of 0.33 is given, along with a 95% confidence interval and a p-value indicating the statistical significance of the difference between the two groups.*

FDA Label Image

Spl-sunitinib-figure2 (Spl Sunitinib Figure2)

This appears to be a table presenting survival probability data for two different treatments (Sunitinib and IFN-a) consisting of two columns - "Time (weeks)" and "Free Survival Probability (%)" - along with the number of patients at risk, hazard ratio, and confidence interval. However, there seem to be some missing or unreadable characters, making it difficult to provide more detailed information.*

FDA Label Image

Spl-sunitinib-figure3 (Spl Sunitinib Figure3)

FDA Label Image

Spl-sunitinib-figure4 (Spl Sunitinib Figure4)

FDA Label Image

Spl-sunitinib-malate-structure (Spl Sunitinib Malate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.